Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients

Summary

Virgin Coconut Oil (VCO) contains multiple compounds which have antibacterial, antiviral, and immunomodulatory properties. The role of VCO as an antivirus to treat COVID-19 requires further studies. A previous study has investigated the used of 30 ml of VCO to healthy volunteers for a month and reported no side effect. Here the investigators conduct a pilot trial to investigate the effect of VCO towards the clinical outcomes of COVID-19 patients in Indonesia.

Timeline

Start

2020-06-01

Primary completion

2020-12-31

Completion

2020-12-31

Drugs

Indications